Cernevit Baxter injection powder supplement vitamins and minerals (10 vials)
Dosage form Box of 10 vials
Specifications Vitamin A, Vitamin D3, Tocoferol, Vitamin B1, Vitamin B2, Vitamin B6, Vitamin B12, Folic Acid, Dexpanthenol, Biotin, Vitamin PP, Glycine, Glycocholic Acid, Lecithin
Ingredient Pierre Fabre
Ingredient
| Composition information | Content |
| Vitamin A | 3500iu |
| Vitamin D3 | 220iu |
| Tocoferol | 10.2mg |
| Vitamin B1 | 3.51mg |
| Vitamin B2 | 4.14mg |
| Vitamin B6 | 4.53mg |
| Vitamin B12 | 0.006mg |
| Folic Acid | 0.414mg |
| Dexpanthenol | 16.15mg |
| Biotin | 0.069mg |
| Vitamin PP | 46mg |
| Glycine | 250mg |
| Glycocholic acid | 140mg |
| Lecithin | 112.5mg |
Uses
indications
Cernevit Baxter injection is indicated in the following cases:
Dynamic pharmacokinetics
with patients using Cernevit, plasma concentrations of vitamins A, D, E are recovered and maintained at a normal level for a long time nutrition. The pharmacokinetics of Cernevit is a collection of properties of each component of the 12 vitamins.
Before taking Cernevit Baxter injection powder supplement vitamins and minerals (10 vials)
How to use
pump 5 ml of distilled water injected into the vial and shake gently to dissolve the powder. The solution after dissolved is slowly intravenously (at least 10 minutes) or intravenously when mixed with physiological saline or 5%glucose solution.
Cernevit can be pumped into a mixture of intravenous sugars combined with carbohydrates, lipid, amino acids, electrolytes and trace elements with the condition that has been checked for compatibility and stability. If intravenous ceremevit transmission should be slowly transmitted. If intravenous injection, must be injected slowly (at least 10 minutes).
Dosage
Adults and children over 11 years old use 1 bottle per day.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do
do when overdose? What to do when you forget 1 dose?
Side Effects
When using Cernevit, you may experience unwanted effects (ADR).
Unknown frequency
Skin and soft tissue: itching, pain at the injection/transmission position.
Instructions on how to handle ADR
When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
contraindicated
Cernevit drugs contraindicated in the following cases:
Hypersensitivity to active ingredients, especially vitamin B1.
Be cautious when used
Precautions when taking Cernevit in patients who are taking vitamin A from other sources. After intravenous bolus injection, the average increase in SGPT enzyme is recorded in several patients with bowelitis. The level of increase will recover quickly after stopping the drug.
Effects on the liver:
Recommendations to monitor liver function in patients using Cernevit, especially in jaundice patients with hepatitis or have bile stasis.
Patients with liver and kidney failure:
may need to personalize the needs of vitamin supplements.
Need to monitor the clinical status and vitamin levels on patients using venous multivitamins as a single source of vitamin for a long time.
Use drugs in patients with vitamin B12 deficiency:
It is advisable to evaluate the condition of vitamin B12 before starting to use Cernevit in patients at risk of vitamin B12 deficiency and/or when there is a Cernevit indication for several weeks. The effectiveness of Vitamin B12 deficiency requires the provision of Cyanocobalamin doses higher than the dose in Cernevit.
affect clinical tests:
Depending on the drug used, the presence of ascorbbic acid in the blood and urine can lead to wrong reading results in blood sugar and urine tests.
The ability to drive and operate machinery
There is no information on the influence of Cernevit on the ability to drive and operate machinery.
Pregnancy
The use of Cernevit in pregnant women has not been studied.
The period of breastfeeding
Vitamins are excreted through breast milk, the drug is recommended not to be used for women who are breastfeeding.
Drug interaction
It is necessary to properly control the interaction between vitamins in Cernevit and other agents including:
Agents that can cause brain tumors: The risk of growing brain tumor increases when combined with vitamin A; Alcohol (overuse of chronic); Increased risk of liver toxicity due to vitamin A; anti -epilepsy drugs.
Folic acid can reduce the concentration of anti -epileptic drugs in serum and increase the risk of convulsions.
Anti -thrombocytes: Vitamin E can inhibit platelet function.
High -dose aspirin: can reduce folic acid levels due to increased urine excretion.
Some anti -epileptic drugs: can cause folat, pyridoxine and vitamin D.
Some antiviral drugs: related to reducing vitamin D. The reduction of vitamin D metabolism may be related to protease inhibitors.
chloramphenicol: Can inhibit the hematological response of vitamin B12 therapy.
Antiseptic antidote due to iron poisoning: Interactive drugs increases the risk of iron heart failure due to increased iron mobilization when supplementing with vitamin C above physiological level.
Ethionamid: may cause pyridoxin deficiency.
fluoroquinolon: Increased risk of poisoning when combining folic acid.
Folat antagonistic drugs: hinder the conversion of folats into active metabolites and reduce the effectiveness of folat supplementation.
Anti -metabolic folat: Folic acid supplements can reduce the effectiveness of folat metabolic substances.
Pyridoxin antagonists: can cause pyridoxin deficiency.
Retinoids, Bexaroten: Increasing the risk of poisoning when using Vitamin A simultaneously.
Theophylllin: may cause pyridoxin deficiency.
The drug is linked to alpha1-acid glycoprotein: Glycocholic acid levels increase when using Cernevit simultaneously. Patients need to monitor closely when using two drugs.
Storage
Store at temperatures below 30 ° C, avoid light
Other drugs
- ASPAR HOT LEMON POWDERS
- Karvezide
- LIPOFUNDIN MCT/LCT 20% EMULSION FOR INFUSION
- MICROGYNON 30 TABLETS
- MICTONORM 15 MG COATED TABLETS
- PANADOL ADVANCE 500 MG TABLETS
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions